AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

MTF Biologics Joins Lineup at The Aesthetic Meeting 2019

May 16, 2019

EDISON, N.J.--(BUSINESS WIRE)--May 16, 2019--

MTF Biologics, a leading nonprofit tissue bank dedicated to saving and healing lives, will showcase its cosmetic and reconstructive surgery portfolio at The Aesthetic Meeting 2019, held May 16 – 21, 2019 at the New Orleans Convention Center.

The nonprofit tissue bank will feature its collection of allograft and medical device solutions in diverse areas of plastic and reconstructive medicine, including cosmetic facial reconstruction, rhinoplasty, and fat harvesting and grafting. It also will offer conference participants a unique opportunity to see, touch and feel the innovative tissue grafts and products, and speak to surgeons who use them, at the exclusive Tissue Experience Station at the booth #845.

The Tissue Experience Station schedule and surgeons, include:

  • Saturday, May 18:
    • 10:30 a.m. – Drs. Jay Calvert & Farzad Nahai
    • 12:30 p.m. – Dr. Regina Fearmonti
    • 3:30 p.m. – Dr. James Fernau
  • Sunday, May 19:
    • 10:00 a.m. – Dr. Kevin Nini
    • 12:30 p.m. – Dr. James Fernau
  • Monday, May 20:
    • 10:30 a.m. – Dr. James Fernau
    • 12:30 p.m. – Dr. Rod Rohrich

Innovative solutions MTF Biologics will highlight at The Aesthetic Meeting, include:

  • Renuva®: An allograft adipose matrix that conveniently treats small volume soft tissue defects in the face, breast and body. An alternative to fat grafting, Renuva is made from donated human adipose, or fat. It is produced from the highest quality tissue and gives patients the same benefits as fat grafting without the need for liposuction. A natural injection that does not require general anesthesia, Renuva can be administered in a doctor’s office.

    Renuva will be presented by Dr. Haideh Hirmand at Hot Topics on Friday, May 17 at 1 p.m., and by Dr. Barbara Hayden on Sunday, May 19 at 10:30 a.m.
  • Meso BioMatrix®: A strong, thin xenograft tissue form for plastic and reconstructive surgery that offers surgeons a new option for patients requiring soft tissue repair and/or reinforcement such as suture line reinforcement and muscle flap reinforcement.
  • Profile®:  A pre-shaped, costal cartilage allograft, Profile is used in rhinoplasty procedures. It allows surgeons to avoid having to perform additional surgery to obtain cartilage from a patient’s ear or rib, leading to less post-operative pain and scarring. Because Profile is made from human tissue, it is natural to the patient’s own body, which means fewer chances of infection or extrusion than synthetic implants.

    Profile Costal Cartilage, Renuva and Meso Biomatrix will be featured in the Modern Techniques in Rhinoplasty Cadaver Workshop on Friday, May 17 at 2 p.m.
  • LipoGrafter®: LipoGrafter is a practical fat grafting solution designed for better graft survival. The easy-to-use technology offers surgeons a safe and efficient way to harvest a patient’s fat and deliver it in areas where the patient may require or seek additional volume.

To learn more, visit the MTF Biologics booth #845 at The Aesthetic Meeting 2019.

About MTF Biologics

MTF Biologics, also known as the Musculoskeletal Transplant Foundation, is a nonprofit organization based in Edison, N.J. It is a consortium comprised of leading organ procurement organizations, tissue recovery organizations and academic medical institutions, and governed by a board of surgeons who are leading experts in tissue transplantation. As the world’s largest tissue bank, MTF Biologics saves and heals lives by honoring donated gifts, serving patients and advancing science. Since its inception in 1987, the organization has received tissue from more than 132,000 donors and distributed more than 8.6 million grafts for transplantation. Through its IIAM subsidiary, it has placed more than 58,000 non-transplantable organs for research. Through its Statline subsidiary, it has managed more than 11.3 million donor referrals. For more information, visit www.mtfbiologics.org.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190516005126/en/

Christian Lail, 615-610-0307,christian.lail@dvlseigenthaler.com

KEYWORD: UNITED STATES NORTH AMERICA LOUISIANA NEW JERSEY

INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY MEDICAL DEVICES OTHER HEALTH

SOURCE: MTF Biologics

Copyright Business Wire 2019.

PUB: 05/16/2019 08:00 AM/DISC: 05/16/2019 08:01 AM

http://www.businesswire.com/news/home/20190516005126/en